Abstract: The invention provides compositions and methods for treating a disease or disorder associated with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.
Type:
Application
Filed:
August 5, 2011
Publication date:
December 5, 2013
Applicant:
Genzyem Corporation
Inventors:
James Stefano, Clark Pan, Huawei Qiu, Michael O'Callaghan, Gloria Matthews